BioChaperone PDGF spray for diabetic foot ulcers

Press Release:*Adocia announces its phase III development program for the treatment of diabetic foot ulcer*—Quote—Adocia (NYSE Euronext Paris: FR0011184241 – ADOC), a biotechnology company specialized in the development of ‘best-in-class’ medicines from already approved therapeutic proteins…

Read more:
BioChaperone PDGF spray for diabetic foot ulcers

This entry was posted in Uncategorized and tagged , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *